-+ 0.00%
-+ 0.00%
-+ 0.00%

Wedbush Maintains Underperform on Praxis Precision Medicine, Raises Price Target to $130

Benzinga·02/20/2026 13:24:39
Listen to the news
Wedbush analyst Laura Chico maintains Praxis Precision Medicine (NASDAQ:PRAX) with a Underperform and raises the price target from $95 to $130.